Skip to Content
Merck
CN

SML4044

TRC051384

≥98% (HPLC)

Synonym(s):

1-[2-(Morpholin-4-yl)ethyl]-3-(4-{-3-[6-(morpholin-4-yl)pyridin-2-yl]prop-2-enoyl}phenyl)urea, N-[2-(4-Morpholinyl)ethyl]-N′-[4-[3-[6-(4-morpholinyl)-2-pyridinyl]-1-oxo-2-propen-1-yl]phenyl]urea, TRC 051384 free base, TRC-051384 free base

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C25H31N5O4
CAS Number:
Molecular Weight:
465.54
NACRES:
NA.21
Assay:
≥98% (HPLC)
Form:
powder
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Segment

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

O=C(C1=CC=C(NC(NCCN2CCOCC2)=O)C=C1)/C=C/C3=CC=CC(N4CCOCC4)=N3

Biochem/physiol Actions

Potent heat shock protein 70 inducer with therapeutic efficacy in a rat model of transient cerebral ischemia in vivo.
TRC051384 is a potent heat shock protein 70 inducer (fold of HSP70 mRNA induction in 4h at 6.25/12.5 µM = 19/210 in HeLa & 10/84 in primary neonatal rat cerebellum neurons) that increases HSF1 transcriptional activity in HeLa cells (by 2.1/3.3-fold at 12.5/2.5 µM) and reduces LPS-induced TNF-α expression in THP-1 cells (% inhibition/conc. = 60/6.25 µM & 90/12.5 µM). TRC051384 reduces neuronal injury and disability in a rat model of transient cerebral ischemia in vivo (9 mg/kg 4h or 8h post onset of ischemia, then 4.5 mg/kg every 2h for 48h via i.p.).


Storage Class

11 - Combustible Solids



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library